The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

First-in-human pancreatic cancer trial at WVU tests an implant that delivers chemotherapy directly into tumors using low-voltage electric pulses. The WVU Cancer Institute is helping lead a global ...

A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

A thumbnail-sized chip detected pancreatic cancer from blood plasma with 97% accuracy, beating the standard needle biopsy (79 ...

Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

A new blood test designed to detect early signs of pancreatic cancer is being trialled in the UK. The genomic test analyses blood samples to identify markers of the deadly disease, which often ...

A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Getty Researchers have developed an inexpensive blood test that they say can detect ...

Researchers at ASCO presented the results of a landmark clinical trial testing daraxonrasib in patients with advanced pancreatic cancer.